Ƶ

COMPARE Trial: Peter C. Smits, MD, PhD

Ƶ MedicalToday

WASHINGTON -- In this exclusive press conference, Dr. Smits presents two-year results from a prospective randomized trial of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease.